Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report - Nature Medicine

A unique case from the Colombian cohort of autosomal dominant Alzheimer’s disease is reported in which disease progression is substantially delayed despite unusually high amyloid plaque pathology, possibly related to a rare mutation in APOE3.